Track 7 : Patient organizations and their role in drug development or clinical research

Rare disease drug development could benefit substantially from increased patient engagement and input to enhance understanding of the key aspects of disease impact, ways to measure these impacts and patients' perspectives on the benefit-risk profile of potential therapies.

 

    Related Conference of Track 7 : Patient organizations and their role in drug development or clinical research

    October 21-22, 2019

    15th World Congress on Infection Prevention and Control

    ZURICH | SWITZERLAND Venue: Movenpick Hotel Zürich Airport
    November 25-26, 2019

    2nd World Congress on Rare Diseases

    Dubai, UAE
    January 27-28, 2020

    3rd Global Experts Meeting on Infectious Diseases

    | Bangkok, Thailand
    February 24-25, 2020

    7th International Congress on Infectious Diseases

    Berlin, Germany
    March 11-12, 2020

    8th International Conference on HIV AIDS STD & STIs

    Barcelona, Spain
    March 27-28, 2020

    5th Annual Congress on Infectious Diseases

    Barcelona, Spain
    May 18-19, 2020

    7th Global Congress on Rare Diseases & Orphan Drug

    Istanbul, Turkey
    July 22-23, 2020

    10th World Congress on Rare Diseases and Orphan Drugs

    Barcelona, Spain
    October 05-06, 2020

    12th Euro-Global Conference on Infectious Diseases

    Vienna, Austria
    October 12-13, 2020

    7th International Conference on Infectious Diseases & Antibiotics

    Prague, Czech republic
    September 28-29, 2020

    13th Global Infections Conference

    | Singapore
    December 06-07, 2021

    3rd World Congress on Rare Diseases

    Dubai, UAE

    Track 7 : Patient organizations and their role in drug development or clinical research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in